Literature DB >> 22184007

PKM2: a gatekeeper between growth and survival.

Isaac Harris1, Susan McCracken, Tak Wah Mak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22184007      PMCID: PMC3292300          DOI: 10.1038/cr.2011.203

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  16 in total

1.  Pyruvate kinase M2 is a phosphotyrosine-binding protein.

Authors:  Heather R Christofk; Matthew G Vander Heiden; Ning Wu; John M Asara; Lewis C Cantley
Journal:  Nature       Date:  2008-03-13       Impact factor: 49.962

2.  The SUMO-E3 ligase PIAS3 targets pyruvate kinase M2.

Authors:  Gilles A Spoden; Dieter Morandell; Daniela Ehehalt; Marc Fiedler; Pidder Jansen-Dürr; Martin Hermann; Werner Zwerschke
Journal:  J Cell Biochem       Date:  2009-05-15       Impact factor: 4.429

3.  Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses.

Authors:  Dimitrios Anastasiou; George Poulogiannis; John M Asara; Matthew B Boxer; Jian-kang Jiang; Min Shen; Gary Bellinger; Atsuo T Sasaki; Jason W Locasale; Douglas S Auld; Craig J Thomas; Matthew G Vander Heiden; Lewis C Cantley
Journal:  Science       Date:  2011-11-03       Impact factor: 47.728

4.  The dual activity of pyruvate kinase type M2 from chromatin extracts of neoplastic cells.

Authors:  Jan Ignacak; Maria Barbara Stachurska
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2003-03       Impact factor: 2.231

5.  Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death.

Authors:  Attila Steták; Réka Veress; Judit Ovádi; Péter Csermely; György Kéri; Axel Ullrich
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

6.  HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer.

Authors:  Charles J David; Mo Chen; Marcela Assanah; Peter Canoll; James L Manley
Journal:  Nature       Date:  2009-12-13       Impact factor: 49.962

7.  Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.

Authors:  Taro Hitosugi; Sumin Kang; Matthew G Vander Heiden; Tae-Wook Chung; Shannon Elf; Katherine Lythgoe; Shaozhong Dong; Sagar Lonial; Xu Wang; Georgia Z Chen; Jianxin Xie; Ting-Lei Gu; Roberto D Polakiewicz; Johannes L Roesel; Titus J Boggon; Fadlo R Khuri; D Gary Gilliland; Lewis C Cantley; Jonathan Kaufman; Jing Chen
Journal:  Sci Signal       Date:  2009-11-17       Impact factor: 8.192

8.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.

Authors:  Heather R Christofk; Matthew G Vander Heiden; Marian H Harris; Arvind Ramanathan; Robert E Gerszten; Ru Wei; Mark D Fleming; Stuart L Schreiber; Lewis C Cantley
Journal:  Nature       Date:  2008-03-13       Impact factor: 49.962

9.  Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription.

Authors:  Jungwoon Lee; Hye Kyoung Kim; Yong-Mahn Han; Jungho Kim
Journal:  Int J Biochem Cell Biol       Date:  2007-11-29       Impact factor: 5.085

10.  Regulation of cell proliferation by interleukin-3-induced nuclear translocation of pyruvate kinase.

Authors:  Akemi Hoshino; John A Hirst; Hodaka Fujii
Journal:  J Biol Chem       Date:  2007-04-19       Impact factor: 5.157

View more
  24 in total

1.  Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.

Authors:  Tieying Dong; Xinmei Kang; Zhaoliang Liu; Shu Zhao; Wenjie Ma; Qijia Xuan; Hang Liu; Zhipeng Wang; Qingyuan Zhang
Journal:  Tumour Biol       Date:  2015-12-29

2.  Oncoprotein HBXIP induces PKM2 via transcription factor E2F1 to promote cell proliferation in ER-positive breast cancer.

Authors:  Bo-Wen Liu; Tian-Jiao Wang; Lei-Lei Li; Lu Zhang; Yun-Xia Liu; Jin-Yan Feng; Yue Wu; Fei-Fei Xu; Quan-Sheng Zhang; Ming-Zhu Bao; Wei-Ying Zhang; Li-Hong Ye
Journal:  Acta Pharmacol Sin       Date:  2018-06-20       Impact factor: 6.150

Review 3.  Emerging roles of aerobic glycolysis in breast cancer.

Authors:  Z Wu; J Wu; Q Zhao; S Fu; J Jin
Journal:  Clin Transl Oncol       Date:  2019-07-29       Impact factor: 3.405

4.  Oxidative stress stimulates invasive potential in rat C6 and human U-87 MG glioblastoma cells via activation and cross-talk between PKM2, ENPP2 and APE1 enzymes.

Authors:  Ravi P Cholia; Monisha Dhiman; Raj Kumar; Anil K Mantha
Journal:  Metab Brain Dis       Date:  2018-05-02       Impact factor: 3.584

5.  Comparison of Hepatic NRF2 and Aryl Hydrocarbon Receptor Binding in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Treated Mice Demonstrates NRF2-Independent PKM2 Induction.

Authors:  Rance Nault; Claire M Doskey; Kelly A Fader; Cheryl E Rockwell; Tim Zacharewski
Journal:  Mol Pharmacol       Date:  2018-05-11       Impact factor: 4.436

6.  Pyruvate kinase M2 regulates apoptosis of intestinal epithelial cells in Crohn's disease.

Authors:  Qiyun Tang; Qianqian Ji; Weiwei Xia; Liren Li; Jian'an Bai; Runzhou Ni; Yongwei Qin
Journal:  Dig Dis Sci       Date:  2014-05-11       Impact factor: 3.199

7.  Selective GPR55 antagonism reduces chemoresistance in cancer cells.

Authors:  Nagendra S Singh; Michel Bernier; Irving W Wainer
Journal:  Pharmacol Res       Date:  2016-07-14       Impact factor: 7.658

8.  Molecular simulation of Tyr105 phosphorylated pyruvate kinase M2 to understand its structure and dynamics.

Authors:  Ponnusamy Kalaiarasan; Naidu Subbarao; Rameshwar Nk Bamezai
Journal:  J Mol Model       Date:  2014-09-11       Impact factor: 1.810

Review 9.  Tumor suppressor p53 and its mutants in cancer metabolism.

Authors:  Juan Liu; Cen Zhang; Wenwei Hu; Zhaohui Feng
Journal:  Cancer Lett       Date:  2013-12-24       Impact factor: 8.679

10.  Pyruvate Kinase Isoform Switching and Hepatic Metabolic Reprogramming by the Environmental Contaminant 2,3,7,8-Tetrachlorodibenzo-p-Dioxin.

Authors:  Rance Nault; Kelly A Fader; Mathew P Kirby; Shaimaa Ahmed; Jason Matthews; A Daniel Jones; Sophia Y Lunt; Timothy R Zacharewski
Journal:  Toxicol Sci       Date:  2015-11-17       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.